Marie C. Bretagne
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Rechallenge After Immune Checkpoint Inhibitors Myocarditis: Evidence and a Practical Framework: JACC Cardio-Oncology Primer.
Journal: JACC. CardioOncology
Published: April 07, 2026
Restarting Immune Checkpoint Inhibitors After ICI Myocarditis: A Prospective Cohort.
Journal: Circulation
Published: April 06, 2026
Rechallenge After Severe Immune Checkpoint Inhibitor Myocarditis: Venturing Into the Unknown.
Journal: JACC. CardioOncology
Published: January 22, 2025
Case Report: Immune checkpoint-inhibitor related myotoxicity monitoring using a comprehensive cardiothoracic MRI approach: insights from a clinical case.
Journal: Frontiers in cardiovascular medicine
Published: November 12, 2024
Abatacept dose-finding phase II triaL for immune checkpoint inhibitors myocarditis (ACHLYS) trial design.
Journal: Archives of cardiovascular diseases
Published: September 20, 2024
Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis.
Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis.
Journal: Nature medicine
Published: November 27, 2023
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis.
Journal: Nature medicine
Published: February 06, 2023
Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis.
Journal: Cancer discovery
Published: October 18, 2022
Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced Myocarditis.
Journal: JACC. CardioOncology
Published: June 01, 2022
Last Updated: 09/26/2026